The pharmacy association said it was worried some patients were accessing the drugs inappropriately amid a surge in demand.

Weight-loss jabs, known as GLP-1 receptor agonists, work by reducing food cravings. The NPA has previously urged patients to ...

Eli Lilly and Novo Nordisk continue to ramp production facilities and capacity for booming weight-loss drugs like Wegovy ... and demand issues have led to a boom in pharmaceutical cybercrime ...